Back to Stocks

Torrent Pharmaceuticals Limited

TORNTPHARMNSEHealthcare

Torrent Pharmaceuticals Limited
4,252.70 1.00%(+41.90)

Previous Close

4,210.80

Last Updated

20 Mar, 07:25 am

Market Cap

N/A

P/E Ratio

63.520542

52W High

4,482.90

52W Low

3,101.60

Open

₹4,250.00

High

₹4,257.40

Low

₹4,199.00

Volume

89,475

Price Chart with Technical Indicators

• Blue line: Stock price

• Yellow dashed line: 20-day moving average

• Red dashed line: 50-day moving average

• Gray line: Trading volume (scaled for visualization)

Performance Analysis

52W Range Position

83.3%

Above midpoint

From 52W High

5.1%

From 52W Low

+37.1%

Average Price

₹4210.80

Trading Metrics

Volume

89,475

Avg Volume

2,03,284

Volume Ratio

0.44x

Low activity

Volatility

N/A

Moderate

Financial Fundamentals

Profit

0.00 Cr

Debt

0.00 Cr

Risk Assessment

Overall Risk LevelLow

Price Stability

Volatile

Market Position

Strong

Liquidity

Moderate

Valuation Metrics

P/E Ratio

63.520542

Overvalued

About Torrent Pharmaceuticals Limited

Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally. The company offers products in various therapeutic areas, including anti-diabetic, anti-microbial, cardiovascular, urology, gynecology, oncology, gastro-intestinal, nephrology, neuro-psychiatric, cosmo-dermatology, pain management, anti-infective, and miscellaneous, as well as vitamins, minerals, and nutrients. It also provides contract manufacturing services. The company offers its products under Tedibar, Shelcal, Unienzyme, and Ahaglow brands. The company was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. The company was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Limited is a subsidiary of Torrent Investments Limited.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Latest News

No news available for this stock.